Health Sovereignty

Your data, not a population average

Conventional medicine treats you as the statistical average patient. Your body isn't average.

This page is deliberately not about supplements or cure claims — it's about tools that show you real data about your own body (glucose response, biomarkers, recovery, sleep) so you can make informed decisions and have a genuinely useful conversation with a doctor, instead of guessing or accepting a one-size-fits-all protocol. Every product here operates within FDA's "general wellness" framework — data and information, not diagnosis or treatment — and we've flagged the two products in this space that have run into regulatory trouble for crossing that exact line.

Affiliate status: not yet established. Links below go directly to each company's own site — no affiliate relationship exists yet with anything on this page. This is also not medical advice: everything here gives you information, not a diagnosis or treatment plan. Talk to a doctor about what your data means for you.

Continuous glucose monitoring

Now available over-the-counter in the US, no prescription needed — a genuinely low-friction way to see how your own body responds to food, stress, and sleep.

Dexcom Stelo Simplest, cleanest regulatory story

$99 for two 15-day sensors, or $89/month subscription · FDA-cleared OTC, March 2024

FDA-cleared for over-the-counter sale to non-insulin-using adults — no prescription, no telehealth gatekeeping, no middleman app subscription required if you just want the raw data. HSA/FSA eligible.

Visit Dexcom Stelo →

Nutrisense Best dashboard/coaching layer

$179/month · uses Stelo sensors, no prescription required

Builds a coaching and analytics layer on top of OTC sensors, with an option for insurance-covered dietitian calls.

Watch out: raised its price from $149 to $179/month in June 2026 with complaints about how it was communicated, and some users report difficulty canceling. Confirm current pricing and cancellation terms before subscribing.

Visit Nutrisense →

Comprehensive lab testing

InsideTracker No overclaimed "clinician review"

From $149/year, Ultimate panel (54 biomarkers) $699/year · founded 2009

The longest-running player in this category. Recommendations come from an algorithm, not a claimed physician sign-off — which we consider a point in its favor: there's no gap between what's marketed and what's actually delivered, unlike some competitors whose "physician-reviewed" claims are closer to an automated flag-check than an actual consult.

Visit InsideTracker →

Everlywell If you want an actual licensed physician involved

$49–$399 per test, à la carte · 30+ individual test kits

Unlike subscription-first competitors, Everlywell sells individual tests as needed. Results are reviewed by a board-certified, independently licensed physician who determines test appropriateness — and the company states plainly that its tests are laboratory-developed tests, not FDA-approved, rather than implying a level of clearance they don't have.

Visit Everlywell →

Recovery & sleep wearables

Oura Ring

Ring from $349 + required $5.99–6.99/month membership

Sleep, recovery, and readiness tracking in a ring form factor rather than a wrist band.

Watch out: the membership is mandatory to access most metrics, not optional. Oura is also facing an active class action (motion to dismiss denied, January 2026) alleging its marketing implied core features would stay free — worth knowing before buying, even though the hardware and tracking itself aren't in dispute.

Visit Oura →

Why Whoop isn't listed as a pick here

Whoop received an FDA warning letter in July 2025 stating its "Blood Pressure Insights" feature functioned as an unapproved medical device — the exact line this page is built to stay on the safe side of. It's also facing an active privacy class action alleging vitals and video-viewing data were shared with third parties without consent, and drew backlash in 2025 for charging existing subscribers $49–79 to upgrade hardware. None of this makes Whoop hardware bad at what it measures, but it's a live example of a company in this exact category crossing the data-vs-diagnosis line, and worth knowing about rather than recommending uncritically.

Home environmental health

AquaTru Certified, not just marketed

$449 (Classic) · NSF/ANSI certified by IAPMO, removes 83–84 contaminants

Independently, third-party certified (NSF/ANSI standards 41, 53, 58, 401, P47) — its contaminant-removal claims, including PFAS/lead/chromium-6/fluoride, are independently verified, not just company-reported.

Visit AquaTru →

Why Berkey isn't listed

Berkey filters are not NSF/ANSI certified, are banned from retail sale in California under the state's lead-free certification law, and are the subject of an active class action (filed 2022, unresolved as of early 2026) alleging their virus/bacteria/heavy-metal removal claims aren't backed by independent testing. Given this page's whole purpose is steering away from exactly this kind of unsubstantiated-efficacy problem, we're not recommending it, regardless of how well-known the brand is.

IQAir HealthPro Plus

~$900 upfront + ~$365/year in filters · HyperHEPA filtration, independently tested

Independently tested and certified to capture 99.5% of particles down to 0.003 microns — well beyond standard HEPA's 0.3-micron spec, a verifiable claim rather than vague "medical-grade" marketing.

Watch out: the highest ongoing running cost of anything on this page. Factor the ~$365/year filter/electricity cost into your decision, not just the sticker price.

Visit IQAir →

The rule this whole page follows

The FDA's own guidance draws a real, specific line: a product intended solely for general wellness — helping you see and track something about your body, not diagnose or treat a named disease — is treated very differently than a product marketed to diagnose, treat, mitigate, or cure a condition. That's the difference between "this shows you your glucose response to a meal" (fine) and "this treats your blood sugar" (regulated, and the reason a well-known natural-health publisher was hit with a $5.3 million FTC settlement and an FDA warning letter for exactly that kind of language). Every product on this page stays on the data side of that line, and where a company has crossed it or come close (Whoop's blood-pressure feature, Berkey's unverified claims), we've said so directly instead of leaving it out quietly.

Get the vetting notes, not just the verdict

We re-check pricing, complaint patterns, and regulatory status periodically — get notified when something on this page changes.